Greg Kearns
Impact in
- Neurology top 5%
- Parkinson's Disease Mechanisms and Treatments
- Neurological disorders and treatments
- Transcranial Magnetic Stimulation Studies
- Botulinum Toxin and Related Neurological Disorders
- Psychiatry and Mental health top 10%
- Fibromyalgia and Chronic Fatigue Syndrome Research
Papers in
-
- Parkinson's Disease Mechanisms and Treatments 2
- Neurological disorders and treatments 1
- Transcranial Magnetic Stimulation Studies 1
- Botulinum Toxin and Related Neurological Disorders 1
-
- Antibiotics Pharmacokinetics and Efficacy 1
- Co-authors
- Gary Sexton (3 shared papers)John G. Nutt (3 shared papers)Barry Oken (2 shared papers)Jau‐Shin Lou (2 shared papers)Jau-Shin Lou (1 shared paper)Saskia N. de Wildt (1 shared paper)John N. van den Anker (1 shared paper)Gideon Koren (1 shared paper)
- Journals
- Movement Disorders (2 papers)The Journal of Clinical Pharmacology (1 paper)Archives of Disease in Childhood (1 paper)European Journal of Clinical Pharmacology (1 paper)Clinical Neurophysiology (1 paper)
- Partner nations
- United StatesNetherlandsSwitzerland
In The Last Decade
Greg Kearns
6 papers receiving 381 citations
Peers
Comparison fields: 5 of 60
- Neurology 232
- Psychiatry and Mental health 85
- Neurology 36
- Physical Therapy, Sports Therapy and Rehabilitation 19
- Biological Psychiatry 8
Countries citing papers authored by Greg Kearns
This map shows the geographic impact of Greg Kearns's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Greg Kearns with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Greg Kearns more than expected).
Fields of papers citing papers by Greg Kearns
This network shows the impact of papers produced by Greg Kearns. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Greg Kearns. The network helps show where Greg Kearns may publish in the future.
Co-authors
The 19 scholars most cited alongside Greg Kearns, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 204 | |
| 2 | 2003 | 107 | |
| 3 | 2003 | 51 | |
| 4 | 2009 | 22 | |
| 5 | 2020 | 6 | |
| 6 | 2014 | 5 |
About Greg Kearns
Greg Kearns is a scholar working on Neurology, Pharmacology, Pediatrics, Perinatology and Child Health, Anesthesiology and Pain Medicine and Neurology, having authored 6 papers that have together received 395 indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (2 papers), Neurological disorders and treatments (1 paper), Transcranial Magnetic Stimulation Studies (1 paper), Pain Management and Opioid Use (1 paper), Pharmaceutical studies and practices (1 paper), Pediatric Pain Management Techniques (1 paper), Botulinum Toxin and Related Neurological Disorders (1 paper) and Antibiotics Pharmacokinetics and Efficacy (1 paper). The work is most often cited by research in Neurology (232 citations), Psychiatry and Mental health (85 citations), Neurology (36 citations), Physical Therapy, Sports Therapy and Rehabilitation (19 citations) and Biological Psychiatry (8 citations). Greg Kearns has collaborated with scholars based in United States, Netherlands and Switzerland. Frequent co-authors include Gary Sexton, John G. Nutt, Barry Oken, Jau‐Shin Lou, Jau-Shin Lou, Saskia N. de Wildt, John N. van den Anker, Gideon Koren, Susan M. Abdel‐Rahman and Shamim Qazi. Their work appears in journals such as Movement Disorders, The Journal of Clinical Pharmacology, Archives of Disease in Childhood, European Journal of Clinical Pharmacology and Clinical Neurophysiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.